Master Rollover Protocol for Continued Safety Assessment of Study Drug
| Status: | Available |
|---|---|
| Conditions: | Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/7/2018 |
| Contact: | There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or |
| Phone: | 1-317-615-4559 |
This study is for patients who have participated in a previous study and who continue to
receive benefit to have continued access to study drug and/or treatment.
receive benefit to have continued access to study drug and/or treatment.
Inclusion Criteria:
- To be eligible patients must be currently receiving benefit in a Lilly study that has
met its endpoints or has otherwise stopped.
Exclusion Criteria:
- Patients must not be concurrently enrolled in any other type of medical research
judged not to be scientifically or medically compatible with this study.
We found this trial at
1
site
250 25th Ave N, Ste 100
Nashville, Tennessee 37023
Nashville, Tennessee 37023
615-320-5090
Phone: 317-615-4559
Tennessee Oncology, PLLC Since 1976 Tennessee Oncology has been providing quality cancer care. In 2013,...
Click here to add this to my saved trials
